Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger (SDGR) has granted restricted stock units (RSUs) for 8,365 shares to six newly hired employees on December 12, 2024. The grants were made under the company's 2021 Inducement Equity Incentive Plan and approved by the compensation committee. The RSUs will vest over four years, with 25% vesting after 12 months of continuous service, followed by equal yearly installments of 25% over the next three years. These grants serve as employment inducements in compliance with Nasdaq Listing Rule 5635(c)(4).
Schrödinger (SDGR) ha concesso delle unità di azioni condizionate (RSU) per 8.365 azioni a sei nuovi assunti il 12 dicembre 2024. Le concessioni sono state effettuate nell'ambito del Piano di Incentivazione Azionaria 2021 dell'azienda e approvate dal comitato per la compensazione. Le RSU matureranno nel corso di quattro anni, con il 25% che matura dopo 12 mesi di servizio continuativo, seguito da rate annuali uguali del 25% nei successivi tre anni. Questi contributi fungono da incentivi all'impiego in conformità con la Regola di Quotazione Nasdaq 5635(c)(4).
Schrödinger (SDGR) ha otorgado unidades de acciones restringidas (RSUs) para 8,365 acciones a seis empleados recién contratados el 12 de diciembre de 2024. Las concesiones se realizaron bajo el Plan de Incentivo de Acciones de 2021 de la empresa y fueron aprobadas por el comité de compensación. Las RSUs se adquirirán en un período de cuatro años, con un 25% adquiriéndose tras 12 meses de servicio continuo, seguido de cuotas anuales iguales del 25% durante los próximos tres años. Estas concesiones sirven como incentivos de empleo en cumplimiento con la Regla de Listado 5635(c)(4) de Nasdaq.
슈뢰딩거 (SDGR)는 2024년 12월 12일에 여섯 명의 새롭게 채용된 직원에게 8,365주에 대한 제한 주식 단위를 (RSU) 부여했습니다. 이 부여는 회사의 2021 유도 주식 인센티브 계획에 따라 이루어졌으며 보상 위원회의 승인을 받았습니다. RSU는 4년에 걸쳐 취득됩니다, 12개월의 지속적인 서비스 이후 25%가 취득되고 그 다음 3년 동안 매년 25%씩 균등하게 취득됩니다. 이러한 부여는 Nasdaq 상장 규정 5635(c)(4)에 따른 고용 유인으로 작용합니다.
Schrödinger (SDGR) a accordé des unités d'actions restreintes (RSUs) pour 8 365 actions à six nouveaux employés embauchés le 12 décembre 2024. Ces attributions ont été réalisées dans le cadre du Plan d'Incentive en Actions de 2021 de la société et approuvées par le comité des rémunérations. Les RSUs s'acquerront sur quatre ans, avec 25 % s'acquérant après 12 mois de service continu, suivi de versements annuels égaux de 25 % au cours des trois années suivantes. Ces attributions servent d'incitations à l'emploi conformément à la Règle de Cotation Nasdaq 5635(c)(4).
Schrödinger (SDGR) hat am 12. Dezember 2024 beschränkte Aktieneinheiten (RSUs) für 8.365 Aktien an sechs neu eingestellte Mitarbeiter gewährt. Die Gewährungen erfolgten im Rahmen des Aktienanreizplans 2021 des Unternehmens und wurden vom Vergütungsausschuss genehmigt. Die RSUs werden über einen Zeitraum von vier Jahren fällig, wobei 25 % nach 12 Monaten ununterbrochener Dienstzeit fällig werden, gefolgt von gleichmäßigen jährlichen Raten von 25 % in den nächsten drei Jahren. Diese Gewährungen dienen als Beschäftigungsanreize gemäß der Nasdaq-Listingregel 5635(c)(4).
- None.
- None.
The RSUs vest over four years, with 25 percent of such RSUs vesting when such employee completes 12 months of continuous service measured from the vesting commencement date, and the balance of the RSUs vesting in a series of successive equal yearly installments of 1/4 of the original number of RSUs upon each such employee’s completion of each additional year of service over the three-year period following the first anniversary of the vesting commencement date.
The inducement grants are subject to the terms and conditions of award agreements covering the grants and the company’s 2021 Inducement Equity Incentive Plan.
About Schrödinger
Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger’s software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs and is advancing three clinical-stage oncology programs. Founded in 1990, Schrödinger has approximately 900 employees operating from 15 locations globally. To learn more, visit www.schrodinger.com, follow us on LinkedIn, or visit our blog, Extrapolations.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20241217343331/en/
Investor contact:
Allie Nicodemo
allie.nicodemo@schrodinger.com
Source: Schrödinger
FAQ
How many RSUs did Schrödinger (SDGR) grant on December 12, 2024?
What is the vesting schedule for SDGR's December 2024 RSU grants?
Under which plan were SDGR's December 2024 RSU grants made?
How does SDGR's December 2024 RSU grant comply with Nasdaq rules?
